Danazol and the premenstrual syndrome.
Danazol, an antigonadotrophin, was tested for premenstrual syndrome, showing partial benefit in severe cases but significant side effects in new patients, indicating its use for resistant symptoms, especially with breast tenderness.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (7)
- A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome 1995
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. 1991
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes 1991
- Treatment of the premenstrual syndrome: A double blind placebo controlled cross over study using danazol 1989
- Danazol, Premenstrual Tension, and Uveitis 1989
- Treatment of Premenstrual Syndrome Using Danazol: Preliminary Report of a Placebo-Controlled, Double-Blind, Dose Ranging Study 1985
- Psychosis and the menstrual cycle 1983
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00